Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
United States
Pharma
AZ tacks on $2B to its investment in US manufacturing, R&D
Citing a rosy view of the U.S. economy’s potential for growth, AstraZeneca is boosting its investment in local manufacturing and R&D by $2 billion.
Fraiser Kansteiner
Nov 12, 2024 10:10am
Breaking down BIOSECURE—Industry implications, what comes next
Oct 4, 2024 9:13am
After BIOSECURE passes in House, targeted companies play defense
Sep 10, 2024 10:40am
BIOSECURE Act heads for possible House vote next week
Sep 5, 2024 3:23pm
WuXi Bio continues to snag new projects despite BIOSECURE fears
Aug 22, 2024 9:58am
Lawmakers spotlight studies run at China military hospitals
Aug 20, 2024 2:34pm
